| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |